Abstract
The pharmacokinetics and bioavailability of ofloxacin in 20 healthy male volunteers were studied in an open-label, randomized, two-way crossover study. Ofloxacin (400 mg) was administered either as a 1-h infusion or as an oral tablet. The mean peak concentration after intravenous infusion was 4.30 +/- 0.69 microgram/ml, and that after oral administration was 3.14 +/- 0.53 microgram/ml, occurring 1.74 +/- 0.57 h after dosing. The bioavailability (F) of the oral dosage form of ofloxacin was virtually identical to that of the intravenous form (F = 105% +/- 7%). This complete bioavailability of ofloxacin is supportive of the use of the oral dosage form for the treatment of infections in hospitalized patients either as a replacement for intravenous ofloxacin therapy or in streamlining therapy from the intravenous to the oral route.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Drew R. H., Gallis H. A. Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application. Pharmacotherapy. 1988;8(1):35–46. doi: 10.1002/j.1875-9114.1988.tb04063.x. [DOI] [PubMed] [Google Scholar]
- Farinotti R., Trouvin J. H., Bocquet V., Vermerie N., Carbon C. Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects. Antimicrob Agents Chemother. 1988 Oct;32(10):1590–1592. doi: 10.1128/aac.32.10.1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flor S. Pharmacokinetics of ofloxacin. An overview. Am J Med. 1989 Dec 29;87(6C):24S–30S. [PubMed] [Google Scholar]
- Lode H., Höffken G., Olschewski P., Sievers B., Kirch A., Borner K., Koeppe P. Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother. 1987 Sep;31(9):1338–1342. doi: 10.1128/aac.31.9.1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lode H., Höffken G., Prinzing C., Glatzel P., Wiley R., Olschewski P., Sievers B., Reimnitz D., Borner K., Koeppe P. Comparative pharmacokinetics of new quinolones. Drugs. 1987;34 (Suppl 1):21–25. doi: 10.2165/00003495-198700341-00006. [DOI] [PubMed] [Google Scholar]
- Wise R., Griggs D., Andrews J. M. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule. Rev Infect Dis. 1988 Jan-Feb;10 (Suppl 1):S83–S89. [PubMed] [Google Scholar]